Total Payments
$4,185
2024 Payments
$882.35
Companies
29
Transactions
245
Medicare Patients
12,364
Medicare Billing
$406,222
Payment Breakdown by Category
Food & Beverage$4,185 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,185 | 245 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $659.60 | 35 | $0 (2024) |
| GlaxoSmithKline, LLC. | $532.22 | 43 | $0 (2024) |
| Novo Nordisk Inc | $496.30 | 28 | $0 (2024) |
| PFIZER INC. | $439.21 | 24 | $0 (2024) |
| Amgen Inc. | $255.91 | 17 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $227.15 | 14 | $0 (2024) |
| Lilly USA, LLC | $223.26 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $149.05 | 9 | $0 (2023) |
| Astellas Pharma US Inc | $143.85 | 7 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $141.17 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $882.35 | 49 | GlaxoSmithKline, LLC. ($177.36) |
| 2023 | $1,389 | 84 | ABBVIE INC. ($224.08) |
| 2022 | $1,018 | 59 | ABBVIE INC. ($206.09) |
| 2021 | $895.26 | 53 | AbbVie Inc. ($200.01) |
All Payment Transactions
245 individual payment records from CMS Open Payments — Page 3 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/12/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Diabetes | ||||||
| 12/08/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/04/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/16/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/13/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Gastroenterology | ||||||
| 10/31/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $9.53 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.70 | General |
| Category: RESPIRATORY | ||||||
| 10/27/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Diabetes | ||||||
| 10/23/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Inflammation | ||||||
| 10/20/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: PAIN | ||||||
| 10/12/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Diabetes | ||||||
| 10/09/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: PSYCHIATRY | ||||||
| 10/05/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Diabetes | ||||||
| 10/03/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: UROLOGY | ||||||
| 09/28/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: PAIN | ||||||
| 09/25/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: INSOMNIA | ||||||
| 09/19/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/12/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: NEUROSCIENCE | ||||||
| 09/01/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/24/2023 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 43 | 2,838 | 3,940 | $273,607 | $95,808 |
| 2022 | 44 | 2,829 | 3,918 | $288,610 | $101,739 |
| 2021 | 42 | 3,371 | 4,557 | $318,093 | $112,450 |
| 2020 | 45 | 3,326 | 4,299 | $266,539 | $96,225 |
Total Patients
12,364
Total Services
16,714
Medicare Billing
$406,222
Procedure Codes
174
All Medicare Procedures & Services
174 procedure records from CMS Medicare Utilization — Page 5 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 353 | 557 | $3,342 | $1,668 | 49.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 34 | $6,481 | $1,604 | 24.8% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 11 | 11 | $2,710 | $1,355 | 50.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2021 | 74 | 80 | $2,413 | $1,206 | 50.0% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2021 | 40 | 40 | $1,545 | $772.40 | 50.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 87 | 88 | $2,742 | $733.30 | 26.7% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2021 | 51 | 77 | $1,389 | $694.54 | 50.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 40 | 40 | $1,471 | $663.54 | 45.1% |
| 82728 | Ferritin (blood protein) level | Office | 2021 | 36 | 45 | $1,227 | $613.35 | 50.0% |
| 87086 | Bacterial colony count, urine | Office | 2021 | 50 | 61 | $984.54 | $492.27 | 50.0% |
| 83550 | Iron binding capacity | Office | 2021 | 35 | 45 | $786.60 | $393.30 | 50.0% |
| 83540 | Iron level | Office | 2021 | 35 | 45 | $582.30 | $291.15 | 50.0% |
| 82550 | Creatine kinase (cardiac enzyme) level, total | Office | 2021 | 30 | 39 | $507.78 | $253.89 | 50.0% |
| 82746 | Folic acid level, serum | Office | 2021 | 16 | 16 | $470.40 | $235.20 | 50.0% |
| 82043 | Urine microalbumin (protein) level | Office | 2021 | 35 | 39 | $450.84 | $225.42 | 50.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 13 | 13 | $465.26 | $216.53 | 46.5% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2021 | 23 | 25 | $432.50 | $216.25 | 50.0% |
| 81003 | Automated urinalysis test | Office | 2021 | 80 | 93 | $418.50 | $209.25 | 50.0% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2021 | 35 | 39 | $404.04 | $202.02 | 50.0% |
| 87077 | Bacterial culture for aerobic isolates | Office | 2021 | 23 | 25 | $404.00 | $202.00 | 50.0% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2021 | 17 | 20 | $338.40 | $169.20 | 50.0% |
| 84550 | Uric acid level, blood | Office | 2021 | 31 | 37 | $334.48 | $167.24 | 50.0% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2021 | 53 | 67 | $424.78 | $161.10 | 37.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 12 | 13 | $379.86 | $123.50 | 32.5% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2021 | 21 | 23 | $238.28 | $119.14 | 50.0% |
About Stacey Stinger, ARNP
Stacey Stinger, ARNP is a Family healthcare provider based in Port Charlotte, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/21/2014. The National Provider Identifier (NPI) number assigned to this provider is 1619374451.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stacey Stinger, ARNP has received a total of $4,185 in payments from pharmaceutical and medical device companies, with $882.35 received in 2024. These payments were reported across 245 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,185).
As a Medicare-enrolled provider, Stinger has provided services to 12,364 Medicare beneficiaries, totaling 16,714 services with total Medicare billing of $406,222. Data is available for 4 years (2020–2023), covering 174 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Family
- Location Port Charlotte, FL
- Active Since 11/21/2014
- Last Updated 04/23/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1619374451
Products in Payments
- TRELEGY ELLIPTA (Drug) $395.97
- VRAYLAR (Drug) $312.00
- NURTEC ODT (Drug) $280.10
- Ozempic (Drug) $260.49
- XARELTO (Drug) $227.15
- Otezla (Drug) $192.92
- UBRELVY (Drug) $164.23
- XIFAXAN (Drug) $141.17
- SHINGRIX (Biological) $136.25
- ELIQUIS (Drug) $126.95
- Rybelsus (Drug) $124.49
- QULIPTA (Drug) $114.21
- Tymlos (Drug) $106.67
- NEXLETOL (Drug) $106.29
- ENTRESTO (Drug) $97.87
- COLOGUARD DNA CAPTURE REAGENTS (Device) $80.50
- EMGALITY (Drug) $75.98
- Veozah (Drug) $73.55
- Myrbetriq (Drug) $70.30
- GLASSIA (Biological) $64.97
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Port Charlotte
Annmarie Richardson, Arnp, ARNP
Family — Payments: $10,380
Family $10,380
Stacy Jean
Family — Payments: $7,814
Family $7,814
Monica Gomez, Aprn, APRN
Family — Payments: $4,929
Family $4,929
Rose Marie Mccafferty, Arnp, ARNP
Family — Payments: $4,117
Family $4,117
Jennifer Caluori, Arnp, ARNP
Family — Payments: $3,907
Family $3,907
Natalie Desantis, Aprn, APRN
Family — Payments: $3,298
Family $3,298